Baricitinib

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Baricitinib are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Baricitinib?

The molecule Baricitinib presents a molecular formula of C16H17N7O2S and its IUPAC name is 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile.

Baricitinib (LY3009104) is a small molecule inhibitor of Janus kinase (JAK) enzymes. It was developed by Eli Lilly and Company and Incyte Corporation. Baricitinib is approved in more than 50 countries for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to disease-modifying anti-rheumatic drugs (DMARDs)..

Baricitinib is a selective inhibitor of JAK1 and JAK2 enzymes. These enzymes are involved in signaling pathways that regulate the body's inflammatory response. Inhibition of JAK1 and JAK2 enzymes by baricitinib leads to a reduction in the production of pro-inflammatory cytokines..

The safety and efficacy of baricitinib were evaluated in four clinical trials involving a total of 4,370 adults with active RA. The trials showed that baricitinib significantly improved the signs and symptoms of RA, and reduced the rate of disease progression..

The most common side effects of baricitinib include upper respiratory tract infection, headache, diarrhea, and nausea..

Baricitinib is a novel, orally-administered JAK inhibitor that has demonstrated efficacy and safety in the treatment of RA. Baricitinib represents a new option for the treatment of adults with active RA who have had an inadequate response or intolerance to DMARDs..

3D structure

Cartesian coordinates

Geometry of Baricitinib in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Baricitinib XUZMWHLSFXCVMG-UHFFFAOYSA-N chemical compound 2D structure molecule svg
Baricitinib

 

Molecule descriptors

 
IUPAC name2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
InChI codeInChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChI KeyXUZMWHLSFXCVMG-UHFFFAOYSA-N
SMILESCCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • (1-(Ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)ethanenitrile
  • 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile
  • 1187594-09-7
  • 2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
  • 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
  • 2-[1-ETHYLSULFONYL-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRAZOL-1-YL]AZETIDIN-3-YL]ACETONITRILE
  • 3-AZETIDINEACETONITRILE, 1-(ETHYLSULFONYL)-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]-
  • 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-
  • 3JW
  • A892931
  • AC-27404
  • AM81232
  • AMMD00005
  • BCP04686
  • BCP0726000031
  • BCP9000380
  • BDBM50021656
  • Baricitinib
  • Baricitinib (INCB028050)
  • Baricitinib (INCB28050, LY3009104)
  • Baricitinib (JAN/USAN/INN)
  • Baricitinib (LY3009104)
  • Baricitinib (LY3009104, INCB028050)
  • CCG-268312
  • CS-0724
  • D10308
  • DB11817
  • DS-7641
  • EX-A413
  • FT-0775037
  • GTPL7792
  • HMS3651L17
  • HMS3672M15
  • HMS3747G21
  • HY-15315
  • INCB 028050
  • INCB 28050
  • INCB 28050; INCB28050; LY-3009104;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile
  • INCB-028050
  • INCB028050
  • ISP4442I3Y
  • J-503551
  • LY 3009104
  • LY-3009104
  • LY3009104
  • LY3009104 (phosphate);INCB028050 (phosphate)
  • MFCD21608464
  • MLS006011247
  • NCGC00345839-01
  • NCGC00345839-14
  • NCGC00345839-16
  • NSC-799357
  • NSC799357
  • PB27275
  • Q4860707
  • SB10845
  • SMR004703006
  • SW220096-1
  • olumiant
  • s2851
  • {1-(ethylsulfonyl)-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]azetidin-3-yl}acetonitrile

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC73069247
  • UNII-ISP4442I3Y
  • AKOS022186127
  • AKOS025401933
  • DTXSID30152228
  • CHEMBL2105759
  • CHEBI:95341
  • SCHEMBL871150

Physico-Chemical properties

IUPAC name2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
Molecular formulaC16H17N7O2S
Molecular weight371.417
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity98.51
LogP2.1
Topological polar surface area128.9

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.